A strategy to produce monoclonal antibodies against gp96 by prime-boost regimen using endogenous protein and E. coli heterologously-expressed fragment

2011 ◽  
Vol 18 (6) ◽  
pp. 1857-1864 ◽  
Author(s):  
Yu-dan Zhang ◽  
Sheng Cao ◽  
Song-dong Meng ◽  
George Fu Gao
Keyword(s):  
Monoclonal Antibodies ◽  
E Coli ◽  
Boost Regimen ◽  
Endogenous Protein

scholarly journals Monoclonal antibodies specific to a Ca2+-bound form of lipocortin I distinguish its Ca2+-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2

1990 ◽  
Vol 269 (3) ◽  
pp. 709-715 ◽  
Author(s):  
H Hayashi ◽  
M K Owada ◽  
S Sonobe ◽  
K Domae ◽  
T Yamanouchi ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Phospholipase A2 ◽  
Inhibitory Activity ◽  
Biological Effects ◽  
Free Form ◽  
E Coli ◽  
Phospholipid Binding ◽  
Ef Hand

Lipocortin I, a Ca2(+)-and phospholipid-binding protein without EF-hand structures, has many biological effects in vitro. Its actual role in vivo, however is unknown. We obtained and characterized five monoclonal antibodies to lipocortin I. Two of these monoclonal antibodies (L2 and L4-MAbs) reacted with the Ca(+)-bound form of lipocortin I, but not with the Ca2(+)-free form, both in vivo and in vitro. Lipocortin I required greater than or equal to 10 microM-Ca2+ to bind the two antibodies, and this Ca2+ requirement was not affected by phosphatidylserine. L2-MAb abolished the phospholipase A2 inhibitory activity of lipocortin I and inhibited its binding to Escherichia coli membranes and to phosphatidylserine in vitro. L4-MAb abolished the phospholipase A2 inhibitory activity of lipocortin I, but did not affect its binding to E. coli membranes or to phosphatidylserine. These findings indicated that the inhibition of phospholipase A2 by lipocortin I was not simply due to removal or capping of the substrates in E. coli membranes. Furthermore, an immunofluorescence study using L2-MAb showed the actual existence of Ca2(+)-bound form of lipocortin I in vivo.

Detection of E. coli colonies expressing the v-sis oncogene product with monoclonal antibodies made against synthetic peptides

1985 ◽  
Vol 85 (1) ◽  
pp. 169-182 ◽  
Author(s):  
Roger H. Kennett ◽  
Robert Leunk ◽  
Barbara Meyer ◽  
Vincent Silenzio
Keyword(s):  
Monoclonal Antibodies ◽  
Synthetic Peptides ◽  
E Coli

Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays

1991 ◽  
Vol 37 (8) ◽  
pp. 650-653 ◽  
Author(s):  
Joan I. Speirs ◽  
Mumtaz Akhtar
Keyword(s):  
Escherichia Coli ◽  
Monoclonal Antibody ◽  
Monoclonal Antibodies ◽  
Vero Cell ◽  
Key Words ◽  
E Coli ◽  
Treated Cell ◽  
Cell Extracts ◽  
Immunosorbent Assays ◽  
Key Words Escherichia Coli

Sandwich enzyme-linked immunosorbent assays (ELISAs) were developed to detect Escherichia coli cytotoxins. Wells were coated with monoclonal antibodies from hybridomas 13C4 and (or) 11E10, and biotin conjugates of these antibodies were used for detecting verotoxin 1 and Shiga-like toxin II, respectively. Sensitivities were about 100 and 200 cytotoxic doses, respectively. Verotoxin 2 was detected by ELISA with monoclonal antibody 11E10, but at a sensitivity of only about 4000 cytotoxic doses. ELISA results of polymyxin-treated cell extracts from cultures of 67 E. coli strains were in agreement with Vero cell assay as regards the presence and type of toxin. Key words: Escherichia coli, cytotoxin, ELISA.

Monoclonal antibodies against the capsular K antigen of Escherichia coli (09: K30(A): H12): characterisation and use in analysis of K antigen organisation on the cell surface

1988 ◽  
Vol 34 (10) ◽  
pp. 1159-1165 ◽  
Author(s):  
Mary K. Homonylo ◽  
Sheila J. Wilmot ◽  
Joseph S. Lam ◽  
Leslie A. MacDonald ◽  
Christopher Whitfield
Keyword(s):  
Escherichia Coli ◽  
Molecular Weight ◽  
Monoclonal Antibodies ◽  
Cell Surface ◽  
Molecular Probes ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
E Coli ◽  
Capsular Antigen ◽  
K Antigen

Monoclonal antibodies were produced against the capsular antigen of Escherichia coli serotype K(A)30, using a mouse hybridoma system. The antibodies also recognised the chemically identical capsular polysaccharide produced by Klebsiella K20. Chemical modification of the K30 polysaccharide indicated that the glucuronic acid residues found in the E. coli K30 capsular antigen were important in the epitope recognised by these antibodies. Use of the antibodies as molecular probes revealed the presence of two discrete forms of the K30 antigen. One form was comprised of high molecular weight polysaccharide, present as a surface capsular layer. The second form of the antigen was of low molecular weight and was associated with lipopolysaccharide fractions from cell surface polysaccharide extracts. Separation of lipopolysaccharide fractions using gel chromatography in the presence of detergent showed that the low molecular weight K-antigenic fraction comigrated with a lipopolysaccharide lipid A core fraction present in encapsulated E. coli K30 bacteria but absent in acapsular mutants.

scholarly journals Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed inE. coli

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Anuj Kumar Gupta ◽  
Parvinder Kaur ◽  
Harshada Patil ◽  
Pallavi Kadam ◽  
Paresh B. Bhanushali ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Diagnostic Value ◽  
T Antigen ◽  
Cancer Tissue ◽  
E Coli ◽  
Potential Marker ◽  
Diagnostic Potential ◽  
Elevated Expression ◽  
Altered Gene ◽  
Hybridoma Cell Lines

Aberrant glycosylation is one of the major hallmarks of cancer with altered gene expression signatures of sialyltransferases. ST3Gal-I, a sialyltransferase, is known to play a crucial role in sialylation of T antigen in bladder cancer and it has reported elevated expression in breast carcinogenesis with increased tumor progression stages. The aim of the current study is to develop new monoclonal antibodies (mAbs) against human ST3Gal-I and evaluate their diagnostic potential. We developed a repertoire of stable hybridoma cell lines producing high-affinity IgG antibodies against recombinant human ST3Gal-I, expressed inE. coliBL21-DE3 strain. In order to demonstrate the diagnostic value of the mAbs, various clones were employed for the immunohistochemistry analysis of ST3Gal-I expression in cancerous tissues. Antibodies generated by 7E51C83A10 clone demonstrated a strong and specific fluorescence staining in breast cancer tissue sections and did not exhibit significant background in fibroadenoma sections. In conclusion, the mAbs raised against recombinant ST3Gal-I recognize cellular ST3Gal-I and represent a promising diagnostic tool for the immunodetection of ST3Gal-I expressing cells. Specific-reactivity of clone 7E51C83A10 mAbs towards ST3Gal-I was also confirmed by immunoblotting. Therefore, our observations warrant evaluation of ST3Gal-I as a potential marker for cancer diagnosis at larger scale.

Sign in / Sign up

Export Citation Format

Share Document